← Open Payments lookup

RIMAL B BERA: Open Payments

NPI 1578643656 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$20,526 in 92 payments from 11 companies in 2025. Trend: 2023 $24,642 · 2024 $20,764 · 2025 $20,526

Consulting: $16,289Food & beverage: $2,338Travel & lodging: $1,899
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.21$10,487
Boehringer Ingelheim Pharmaceuticals, Inc.14$8,466
Alkermes, Inc.7$409
Neurocrine BioSciences, Inc.3$304
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$235
ABBVIE INC.7$198
Vanda Pharmaceuticals Inc.13$165
Janssen Pharmaceuticals, Inc13$145
Otsuka Pharmaceutical Development & Commercialization, Inc.1$75
Luye Pharma (USA) Ltd.2$29

Products named: COBENFY, INGREZZA, CAPLYTA, LYBALVI, ARISTADA, FANAPT, INVEGA SUSTENNA, REJOYN.

Industry payments across CA — which companies pay providers there.